Hiroshi Iseki

Hiroshi Iseki

Auto-generated profile, based on publicly available information

Hiroshi Iseki

Tokyo Women's Medical University

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in Neurological Research
Verified
Journal Article
Closed access
TKTakakazu Kawamata
Takakazu Kawamata
HIHiroshi Iseki
Hiroshi Iseki
RIRitsuko Ishizaki
Ritsuko Ishizaki
THTomokatsu Hori
Tomokatsu Hori
Recent advances in endoscopic surgery have developed an endonasal route suitable for pituitary surgery. The main goal of this article is to evaluate benefits of our endoscope-assisted endonasal trans-sphenoidal microsurgery for pituitary tumors in 215 consecutive cases. The pathological classifications of the 215 cases are as follows: 163 pituitary adenomas, 23 Rathke's cleft cysts, 17 craniopharyngiomas, and 12 others. The patients were surgically treated via the endonasal trans-sphenoidal approach using an operating microscope as the primary instrument for tumor resection. Endoscopes were used to complement the operating microscope in visualization. We compared the new approach to the sublabial trans-sphenoidal approach (197 cases) with respect to endocrinological outcomes and surgical complications. Our endonasal trans-sphenoidal approach was beneficial in eliminating the complications of lip numbness, which was often observed in patients undergoing sublabial surgery, and nasal septal perforation. In addition, endocrinological outcome comparable to those in the sublabial group was achieved in the endonasal group. We consider that the endoscope, which allows visualization of areas not seen with the operating microscope, should be used actively in conjunction with the operating microscope that provides three-dimensional visualization and is timesaving. Our surgical method for pituitary tumors provides good results with minimal invasion, by exploiting the advantages of a microscope and an endoscope.

1 January 2005 in Magnetic Resonance in Medical Sciences
Verified
Journal Article
Closed access
PDF file
HIHiroshi Iseki
Hiroshi Iseki
YMYoshihiro Muragaki
Yoshihiro Muragaki
RNRyoichi Nakamura
Ryoichi Nakamura
NONorihiko Ozawa
Norihiko Ozawa
HTHiroki Taniguchi
Hiroki Taniguchi
KTKintomo Takakura
Kintomo Takakura
Malignant brain tumors vary among patients and are characterized by their irregular shapes and infiltration. Localization of functional areas in the brain also differs among patients, and excess removal of tumor near eloquent areas may increase the risk of damage of function, such as motor paresis and speech disturbance. Recent progress in magnetic resonance (MR) imaging technology has enabled acquisition of intraoperative images and totally changed the neurosurgery of malignant brain tumors. Before, surgeons could merely speculate about the results of surgical manipulation and have no certainty about procedure outcomes until postoperative examination. Because intraoperative MR images allow visualization of the size of residual tumor(s) and the positional relationship between the tumor(s) and eloquent areas, surgeons are now able to achieve safe and reliable surgery. As an example, positional error on preoperative MR images caused by shifting of the brain (brain shift), a long-standing annoyance for surgeons, has been resolved using intraoperative MR images for surgical navigation, allowing precise resection. Two types of open-MR imaging scanner, a 0.2- or 0.3-tesla hamburger-type scanner with a horizontal gap and a 0.12- or 0.5-tesla double doughnut-type scanner with a vertical gap, are now available in the operating theater, and 1.5-tesla bore-type scanners are available. A 3.0-tesla bore-type scanner is planned. Intraoperative MR imaging includes diffusion-tensor and diffusion-weighted imaging, which allows visualization of nerve fibers in the white matter, especially the pyramidal tract. Such images are valuable aids in the precise resection of residual lesions of malignant brain tumors near eloquent areas without injuring motor function.

14 May 2004 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
FYFumitaka Yamane
Fumitaka Yamane
YMYoshihiro Muragaki
Yoshihiro Muragaki
TMTakashi Maruyama
Takashi Maruyama
YOYoshikazu Okada
Yoshikazu Okada
HIHiroshi Iseki
Hiroshi Iseki
THTomokatsu Hori
Tomokatsu Hori

1 January 1995 in Journal of Image Guided Surgery
Verified
Journal Article
Closed access
PDF file
KMKen Masamune
Ken Masamune
EKEtsuko Kobayashi
Etsuko Kobayashi
YMYoshitaka Masutani
Yoshitaka Masutani
MSMakoto Suzuki
Makoto Suzuki
TDTakeyoshi Dohi
Takeyoshi Dohi
KTKintomo Takakura
Kintomo Takakura

1 January 1996 in Surgery for Cerebral Stroke
Verified
Journal Article
Closed access
TTTatsuya Tanikawa
Tatsuya Tanikawa
KAKouji Arai
Kouji Arai
HYHiroshi Yonetani
Hiroshi Yonetani
TTTakaomi Taira
Takaomi Taira
FYFumitaka Yamane
Fumitaka Yamane
KTKintomo Takakura
Kintomo Takakura
We analyzed clinical characteristics and surgical results in 44 patients aged 70 years or more with ruptured intracranial aneurysms operated on within 72 hours of hemorrhage. In comparison with a non-aged group of 264 patients aged less than 70 years (126 men and 138 women), the aged group (6 men and 36 women) showed a distinct female preponderance. The most common parent artery of ruptured aneurysm was the internal carotid artery in the aged group, while it was the anterior cerebral artery in the non-aged group. There. was no significant difference in the preoperative clinical grades (Hunt & Kosnik classification) between the two groups. Although delayed ischemic neurological deficit (DIND) appeared in both groups at almost the same frequencies, 32% and 34% for the aged and non-aged group, respectively, the incidence of permanent DIND was higher in the aged group (50%) than in the non-aged group (36%). The comparative studies on surgical results in each clinical grade revealed that outcomes of Grade IV patients were extremely poorer in the aged group (92% poor outcome) than those in the non-aged group (58% poor outcome, p=0.02). Although Grade III patients in the aged group also showed poorer outcomes, it did not reach statistical significance. Overall outcomes in a subgroup of patients aged 70-74 were almost the same as those in the non-aged group. Thus indications for early aneurysm surgery in aged patients, when their ages are under 75 and clinical grades below G III, are determined with the same standards as in non-aged patients. Among the factors accounting for poor outcome of each patient, the incidence of primary brain damage was higher in the aged group (53%) than that in the non-aged group (43%). These results indicate that the major cause of poor outcomes of aged patients is a poor recovery from brain damage due to either primary hemorrhage or symptomatic vasospasm.

1 January 2012 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
YMYoshihiro Muragaki
Yoshihiro Muragaki
MCMikhail Chernov
Mikhail Chernov
KYKitaro Yoshimitsu
Kitaro Yoshimitsu
TSTakashi Suzuki
Takashi Suzuki
HIHiroshi Iseki
Hiroshi Iseki
KTKintomo Takakura
Kintomo Takakura
The objective of this paper is to provide an overview of advanced information‐guided surgical management technology of intracranial gliomas implemented in Japan, represented by the Intelligent Operating Theater at the Tokyo Women’s Medical University, established in 2000, where more than 1000 patients with various intracranial pathology have received neurosurgical treatment with application of the intraoperative MRI, updated neuronavigation, and advanced neurophysiological and histopathological monitoring. Additionally, a dedicated computer‐based system for accumulating, storing, integrating, and analyzing various surgical data was developed, which provided an opportunity for adequate risk management and prediction of the surgical results. Application of these modalities and tools led to significant improvements in both surgical outcome and long‐term patients’ prognosis. Further technological developments, such as new therapeutic robot, dedicated laser, and high intensity focused ultrasound are currently under investigation. The final goal is to integrate all these devices and systems into comprehensive neurosurgical framework.